These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 14724843)

  • 41. Ghrelin ameliorates intestinal barrier dysfunction in experimental colitis by inhibiting the activation of nuclear factor-kappa B.
    Cheng J; Zhang L; Dai W; Mao Y; Li S; Wang J; Li H; Guo C; Fan X
    Biochem Biophys Res Commun; 2015 Feb; 458(1):140-7. PubMed ID: 25634696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Typhlocolitis in NF-kappa B-deficient mice.
    Erdman S; Fox JG; Dangler CA; Feldman D; Horwitz BH
    J Immunol; 2001 Feb; 166(3):1443-7. PubMed ID: 11160181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel.
    Hiraishi K; Kurahara LH; Sumiyoshi M; Hu YP; Koga K; Onitsuka M; Kojima D; Yue L; Takedatsu H; Jian YW; Inoue R
    World J Gastroenterol; 2018 Sep; 24(35):4036-4053. PubMed ID: 30254408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis.
    Fichtner-Feigl S; Young CA; Kitani A; Geissler EK; Schlitt HJ; Strober W
    Gastroenterology; 2008 Dec; 135(6):2003-13, 2013.e1-7. PubMed ID: 18938165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats.
    Xu CL; Guo Y; Qiao L; Ma L; Cheng YY
    World J Gastroenterol; 2018 Feb; 24(6):706-715. PubMed ID: 29456409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tackling the real culprits in Crohn's disease.
    Bonn D
    Lancet; 1998 Jun; 351(9117):1710. PubMed ID: 9734899
    [No Abstract]   [Full Text] [Related]  

  • 47. A diet with lactosucrose supplementation ameliorates trinitrobenzene sulfonic acid-induced colitis in rats.
    Zhou Y; Ruan Z; Zhou X; Huang X; Li H; Wang L; Zhang C; Liu S; Deng Z; Wu G; Yin Y
    Food Funct; 2015 Jan; 6(1):162-72. PubMed ID: 25367079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amelioration of trinitrobenzene sulfonic acid-induced colitis in mice by liquiritigenin.
    Min JK; Lee CH; Jang SE; Park JW; Lim SJ; Kim DH; Bae H; Kim HJ; Cha JM
    J Gastroenterol Hepatol; 2015 May; 30(5):858-65. PubMed ID: 25311527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new model of chronic hapten-induced colitis in young rats.
    Fitzpatrick LR; Meirelles K; Small JS; Puleo FJ; Koltun WA; Cooney RN
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):240-50. PubMed ID: 20118800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of synthetic oligonucleotides for inhibition of factor NF-kappa B].
    Kozlov IA; Kubareva EA; Shabarova ZA
    Mol Biol (Mosk); 1998; 32(3):389-400. PubMed ID: 9720060
    [No Abstract]   [Full Text] [Related]  

  • 51. Apple polysaccharide reduces NF-Kb mediated colitis-associated colon carcinogenesis.
    Zhang D; Mi M; Jiang F; Sun Y; Li Y; Yang L; Fan L; Li Q; Meng J; Yue Z; Liu L; Mei Q
    Nutr Cancer; 2015; 67(1):177-90. PubMed ID: 25412264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice.
    Bennett CF; Kornbrust D; Henry S; Stecker K; Howard R; Cooper S; Dutson S; Hall W; Jacoby HI
    J Pharmacol Exp Ther; 1997 Feb; 280(2):988-1000. PubMed ID: 9023316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carboxyamidotriazole ameliorates experimental colitis by inhibition of cytokine production, nuclear factor-κB activation, and colonic fibrosis.
    Guo L; Ye C; Hao X; Zheng R; Ju R; Wu D; Luo L; Wang C; Li J; Yu X; Zhu L; Zhang D
    J Pharmacol Exp Ther; 2012 Aug; 342(2):356-65. PubMed ID: 22553216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-inflammatory effects of an oxylipin-containing lyophilised biomass from a microalga in a murine recurrent colitis model.
    Ávila-Román J; Talero E; Rodríguez-Luna A; García-Mauriño S; Motilva V
    Br J Nutr; 2016 Dec; 116(12):2044-2052. PubMed ID: 28025954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E; Waks T; Eshhar Z
    Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
    Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
    Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytosolic phospholipase A2 α has a crucial role in the pathogenesis of DSS-induced colitis in mice.
    Rosengarten M; Hadad N; Solomonov Y; Lamprecht S; Levy R
    Eur J Immunol; 2016 Feb; 46(2):400-8. PubMed ID: 26548451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dietary intervention with green dwarf banana flour (Musa sp AAA) prevents intestinal inflammation in a trinitrobenzenesulfonic acid model of rat colitis.
    Scarminio V; Fruet AC; Witaicenis A; Rall VL; Di Stasi LC
    Nutr Res; 2012 Mar; 32(3):202-9. PubMed ID: 22464807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A study comparing the efficacy of antimicrobial agents versus enzyme (P-gp) inducers in the treatment of 2,4,6 trinitrobenzenesulfonic acid-induced colitis in rats.
    Toklu HZ; Kabasakal L; Imeryuz N; Kan B; Celikel C; Cetinel S; Orun O; Yuksel M; Dulger GA
    J Physiol Pharmacol; 2013 Aug; 64(4):439-51. PubMed ID: 24101390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation.
    Kitani A; Fuss IJ; Nakamura K; Schwartz OM; Usui T; Strober W
    J Exp Med; 2000 Jul; 192(1):41-52. PubMed ID: 10880525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.